Navigation Links
Panel endorses active monitoring and delay of treatment for low-risk prostate cancer
Date:12/8/2011

An independent panel convened this week by the National Institutes of Health has concluded that many men with localized, low-risk prostate cancer should be closely monitored, permitting treatment to be delayed until warranted by disease progression. However, monitoring strategiessuch as active surveillancehave not been uniformly studied and available data do not yet point to clear follow-up protocols. The panel recommended standardizing definitions and conducting additional studies to clarify which monitoring strategies are most likely to optimize patient outcomes.

"It's clear that many men would benefit from delaying treatment, but there is no consensus on what constitutes observational strategies and what criteria should be used to determine when treatment might ultimately be needed among closely-monitored men," said Dr. Patricia A. Ganz, conference panel chairperson and director of the Division of Cancer Prevention and Control Research at the Jonsson Comprehensive Cancer Center at the University of California in Los Angeles.

Prostate cancer is the most common non-skin cancer in men in the United States. It is estimated that in 2011, approximately 240,000 men will be newly diagnosed with prostate cancer and 33,000 will die of the disease. More than half of these cancers are localized (confined to the prostate), not aggressive at diagnosis, and unlikely to become life-threatening. However, approximately 90 percent of patients receive immediate treatment, such as surgery or radiation therapy. For many of these patients, treatment has substantial short- and long-term side effects, such as diminished sexual function and loss of urinary control, without clear benefits, such as improved survival. Identifying appropriate management strategies for different subgroups of patients is critical to improving survival and reducing the burden of adverse effects.

Currently, clinicians often describe two alternatives to immediate treatment of low-ri
'/>"/>

Contact: Elizabeth Neilson
elizabeth.neilson@nih.gov
301-496-4999
NIH/National Institutes of Health, Office of Disease Prevention
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Expert Panel Pinpoints Environmental Culprits in Breast Cancer
2. FDA Panels to Weigh Safety of Newer Forms of the Pill
3. Panel of melanoma mutations opens door to new treatment possibilities
4. Many on Medical Guideline Panels Have Conflicts of Interest: Study
5. Panels Rejection of PSA Test Spurs Mixed Reaction From Experts
6. Osteoporosis Drugs Safety Subject of FDA Panel
7. U.S. Panel Recommends Free Coverage of Birth Control
8. FDA Panel Rejects Avastin for Breast Cancer
9. FDA Panels to Weigh Dosing Labels for Kids OTC Fever Relievers
10. FDA Panel Delays Action on Dyes Used in Foods
11. FDA Panel Examines Possible Links Between Food Dyes, ADHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , ... August 01, 2015 , ... Super Bowl 50 will emanate from ... League’s biggest day each year is the Super Bowl. In the two weeks that separate ... from the host venue. The 2016 Super Bowl game will mark the 50th time it ...
(Date:7/31/2015)... ... ... The 2nd annual Ride to Fight On will start and end near the ... to Fight On is a cycling fundraiser that benefits the West Cancer Center, a ... University of Tennessee Health Science Center. A health and wellness festival featuring food, music, ...
(Date:7/31/2015)... Mountain View, CA (PRWEB) , ... July 31, 2015 , ... ... hand for the athletes, judges, media, and VIPs at the 2015 Vans US Open ... best-tasting organic coconut water that can claim “no added sugar” on the market, is ...
(Date:7/31/2015)... ... July 31, 2015 , ... Well-known for its unique pastries ... wedding cakes with custom designs, making life just a little bit sweeter for ... cakes for each customer who orders one. , The bakery provides a full line ...
(Date:7/31/2015)... ... July 31, 2015 , ... Transfinder, a software company based in ... were up 16 percent year-over-year for the first six months ended June 30, 2015 ... expected Transfinder to beat last year’s record-revenue mark of $10.4 million. , “We know ...
Breaking Medicine News(10 mins):Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2
... Soldiers Now Have New Weapon against Chronic Migraines from ... PHP announced today that it is making its new ... service in Iraq and Afghanistan. According to published reports, ... duty in the Middle East are suffering from migraines ...
... DAVID COOK,S ,IDOL, PERFORMANCE WILL BE SOLD ON iTUNES ... Live Version of ,Permanent, Will Be Donated To D.C.-Based ... one year after winning the seventh season of "American ... series in America on Wednesday night to perform "Permanent," ...
... can be a very complicated issue and quite often families ... right questions to ask when they start -- or when ... Philanthropies is adding a new series to its ... ANSWER... "About Long-term Care. This new series will provide ...
... CARROLLTON, Texas, May 20 The Indiana ... representing most of that state,s podiatrists, today ... A-Claim(TM) medical payment solution for physicians, hospitals ... endorsement, the IPMA signed a three-year agreement ...
... at the Helmholtz Centre for Infection Research (HZI) in ... for the first time that bacteria of the ... the protein RovA - which assists them in the ... both the temperature of its host as well as ...
... of May 1st, 2009 in TEDA Tianjin, ChinaTEDA Tianjin, ... research-based contract manufacturer of API,s and intermediates, and Drug ... the opening if its high potency Active Pharmaceutical Ingredient ... This dedicated facility is sited at Asymchem,s TEDA ...
Cached Medicine News:Health News:Clinical Topicals Makes Breakthrough Migraine Treatment Available Free to Soldiers 2Health News:David Cook to Perform 'Permanent' on the American Idol Season Finale Tonight 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 2Health News:Heinz Family Philanthropies (www.heinzfamily.org) Release Questions Families Should Ask About Long-Term Care - 10 Questions to Answer...(www.tenquestionstoanswer.org) 3Health News:Indiana Podiatric Medical Association Endorses A-Claim Payment Solution 2Health News:Bacteria with a built-in thermometer 2Health News:Asymchem Announces Opening of High Potency API and Drug Product Facility 2
(Date:7/30/2015)... , July 30, 2015  OncoGenex Pharmaceuticals, Inc. ... report its second quarter 2015 financial results on Thursday, ... call and live webcast at 4:30 p.m. Eastern Time ... programs and a general corporate update. ... Relations page of the OncoGenex website at www.oncogenex.com ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
(Date:7/30/2015)... 30, 2015 Future Market Insights ... "Continuous Glucose Monitoring Systems Market: Global Industry Analysis and ... the global continuous glucose monitoring systems market was valued ... to reach US$ 788.4 Mn by 2020, registering a ... 2020. Global continuous glucose monitoring systems market ...
Breaking Medicine Technology:TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... Bulletin Board: WDST ), a clinical-stage company developing ... human skin, will present at the Rodman & Renshaw Healthcare ... City from September 12-15, 2010. Regenicin™ President Joe ... EDT to provide a status update on the company,s Pipeline ...
... OMAHA, Neb., Sept. 8 Transgenomic, Inc. (OTC Bulletin ... Tuttle, president and chief executive officer, will deliver the ... Annual Global Investment Conference on Monday, September 13 at ... the Palace Hotel in New York City from September ...
Cached Medicine Technology:Regenicin™ to Present at the Rodman & Renshaw Healthcare Conference 2Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 2Transgenomic to Present at the Rodman & Renshaw 12th Annual Global Investment Conference 3
All Purpose, General Procedure Apron...
The Velcro Apron provides .50mm Pb protection with the added ease of velcro closures. This form-fitting apron offers comfort and protection while at the same time allowing for easy-on/easy-off access...
... apron has the same ... as the standard Cool-Tech™ ... with velcro fasteners at ... as side flaps for ...
Apron,special Proceddure...
Medicine Products: